Finance

Lists
1801:HKG
Innovent Biologics Inc
89,05 HKD
+1,48%
(+1,30) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1801...
Open
91,25 HKD
High
92,45 HKD
Low
88,00 HKD
Mkt. cap
155,56 მლრ.
Avg. vol.
9,91 მლნ.
Volume
9,69 მლნ.
P/E ratio
111,08
52-wk high
112,70 HKD
52-wk low
69,55 HKD
EPS
0,80 HKD
No. of employees
9 ათ.
Open
91,25 HKD
High
92,45 HKD
Low
88,00 HKD
Mkt. cap
155,56 მლრ.
Avg. vol.
9,91 მლნ.
Volume
9,69 მლნ.
P/E ratio
111,08
52-wk high
112,70 HKD
52-wk low
69,55 HKD
EPS
0,80 HKD
No. of employees
9 ათ.
News stories
From web sources and news partners
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOმაიკლ იუ
Employees8,75 ათ.
Founded28 ნოე. 2011
Headquarters-
Sector-
Websiteinnoventbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,54 მლრდ.
3,54 მლრდ.
4,31 მლრდ.
4,31 მლრდ.
Cost of goods sold
845,12 მლნ.
845,12 მლნ.
999,35 მლნ.
999,35 მლნ.
Cost of revenue
845,12 მლნ.
845,12 მლნ.
999,35 მლნ.
999,35 მლნ.
Research and development expenses
807,71 მლნ.
807,71 მლნ.
841,85 მლნ.
841,85 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,91 მლრდ.
1,91 მლრდ.
1,86 მლრდ.
1,86 მლრდ.
Operating expense
2,72 მლრდ.
2,72 მლრდ.
2,71 მლრდ.
2,71 მლრდ.
Total operating expenses
3,56 მლრდ.
3,56 მლრდ.
3,71 მლრდ.
3,71 მლრდ.
Operating income
-19,96 მლნ.
-19,96 მლნ.
602,76 მლნ.
602,76 მლნ.
Other non operating income
45,19 მლნ.
45,19 მლნ.
31,56 მლნ.
31,56 მლნ.
EBT including unusual items
-29,10 მლნ.
-29,10 მლნ.
805,83 მლნ.
805,83 მლნ.
EBT excluding unusual items
-1,59 მლნ.
-1,59 მლნ.
738,07 მლნ.
738,07 მლნ.
Income tax expense
-18,72 მლნ.
-18,72 მლნ.
179,26 მლნ.
179,26 მლნ.
Effective tax rate
64,33%
64,33%
22,25%
22,25%
Other operating expenses
-
-
-
-
Net income
-10,38 მლნ.
-10,38 მლნ.
626,57 მლნ.
626,57 მლნ.
Net profit margin
-0,29%
-0,29%
14,54%
14,54%
Earnings per share
-
-
-
-
Interest and investment income
124,16 მლნ.
124,16 მლნ.
178,13 მლნ.
178,13 მლნ.
Interest expense
-9,17 მლნ.
-9,17 მლნ.
-20,46 მლნ.
-20,46 მლნ.
Net interest expenses
114,99 მლნ.
114,99 მლნ.
157,67 მლნ.
157,67 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
140,29 მლნ.
140,29 მლნ.
761,42 მლნ.
761,42 მლნ.
Gain or loss from assets sale
-71,00 ათ.
-71,00 ათ.
1,36 მლნ.
1,36 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები